Sars-Cov-2 Antigen Oral Fluid Rapid Test – Product code: SC-1286-20
The Covid-19 Antigen Rapid Test Cassette (Oral Fluid) is a rapid chromatographic immunoassay test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in oral fluid samples from individuals with suspected SARS-CoV-2 infection in combination with the clinical presentation and the results of other laboratory tests. The results are for the detection of SARS CoV-2 nucleocapsid protein antigens. During the acute phase of infection, an antigen is usually detectable in upper respiratory tract samples. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine the status of the infection. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent identified may not be the definitive cause of the disease. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management or treatment decisions. Negative results should be treated as suspected and confirmed with a molecular test if necessary for patient management. Negative results should be considered in the context of the patient’s recent exposures, medical history, and the presence of clinical signs and symptoms consistent with COVID-19. The new coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible to it. Currently, patients infected with the new coronavirus are the main source of infection; even asymptomatic infected people can be an infectious source. Based on the current epidemiological survey, the incubation period is 1-14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. In some cases, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found. The COVID-19 Antigen Rapid Test (Oral Fluid) is a qualitative membrane immunoassay for the detection of SARS-CoV-2 nucleocapsid protein antigens in human oral fluid samples. Antibodies to the SARS-CoV 2 nucleocapsid protein line the test line area. During the test, the sample reacts with the antibody-coated particles of the SARS-CoV-2 nucleocapsid protein in the test. The mixture then migrates upward on the membrane by capillary action and reacts with the SARS-CoV-2 nucleocapsid protein antibody in the test line region. If the sample contains SARS-CoV-2 antigens, a colored line will appear in the test line area as a result. If the sample does not contain SARS-CoV-2 antigens, no colored lines will appear in the test line region, indicating a negative result. As a procedural control, a colored line will always appear in the control line region, indicating that the correct volume of sample has been added and that membrane uptake has occurred.